Exercise
Behavioral36 sessions of comprehensive cardiac rehabilitation over 12 weeks
NCT Number: NCT03944668
Comprehensive Cardiovascular Rehabilitation Feasibility After Stroke (CCR FAST) will evaluate the feasibility of enrolling Regions Hospital stroke patients in a Comprehensive Cardiovascular Rehabilitation (CCR) program. CCR will include aerobic exercise and patient education (regarding risk factors and medication compliance), similar to the rehabilitation program for cardiac disease patients. The overall goal of CCR FAST is to demonstrate the feasibility and safety of including stroke patients in a CCR program, while examining the clinical value in reducing stroke recurrence, myocardial infarction, readmission, and mortality in stroke patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
36 sessions of comprehensive cardiac rehabilitation over 12 weeks
Time frame: 12 weeks
75% attendance at comprehensive cardiovascular rehabilitation (CCR) sessions
Time frame: 6 month
Recurrent stroke in follow-up period
Time frame: 6 month
Myocardial infarction in follow-up time
Time frame: 6 month
rate, for a cardiovascular or cerebrovascular indication
Time frame: 6 month
rate, on MRI
Time frame: 6 month
rate
HealthPartners Institute
Other
Acronym: CCRFast
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05559398
Brain Diseases, Cardiovascular Diseases
Bron, France
View Trial DetailsNCT04042584
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT06641050
Brain Diseases, Cardiovascular Diseases
Istanbul, Turkey (Türkiye)
View Trial Details